Harmonization Project Document No . 2 CHEMICAL-SPECIFIC ADJUSTMENT FACTORS FOR INTERSPECIES DIFFERENCES AND HUMAN VARIABILITY : GUIDANCE DOCUMENT FOR USE OF DATA IN DOSE / CONCENTRATION – RESPONSE ASSESSMENT
暂无分享,去创建一个
[1] A. Renwick. Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.
[2] Arun Sharma. Evaluation of certain food additives and contaminants. , 2001, World Health Organization technical report series.
[3] Ipcs,et al. Principles for the assessment of risks to human health from exposure to chemicals , 1999 .
[4] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[5] K Walton,et al. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[6] A G Renwick,et al. Human variability and noncancer risk assessment--an analysis of the default uncertainty factor. , 1998, Regulatory toxicology and pharmacology : RTP.
[7] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[8] REVISED OPINION ON CYCLAMIC ACID AND ITS SODIUM AND CALCIUM SALTS ( Expressed on 9 March 2000 ) , 2022 .
[9] K Walton,et al. Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[10] W. Slob,et al. Mathematical modelling and quantitative methods. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[11] D J Rance,et al. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.
[12] K Walton,et al. Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[13] Ipcs,et al. Assessing human health risks of chemicals; derivation of guidance values for health based exposure limits , 1994 .
[14] A. Renwick,et al. The use of surrogate endpoints to assess potential toxicity in humans. , 2001, Toxicology letters.
[15] G. L. Kedderis,et al. Incorporating human interindividual biotransformation variance in health risk assessment. , 2002, The Science of the total environment.
[16] K Walton,et al. Pathway-Related Factors: The Potential for Human Data to Improve the Scientific Basis of Risk Assessment , 2001 .
[17] L. Lave. Risk Assessment and Management , 2013, Advances in Risk Analysis.